79 results
8-K
EX-99.1
MRMD
Marimed Inc.
6 Mar 24
MariMed Reports Fourth Quarter and Full Year 2023 Earnings
5:06pm
STATEMENTS:
The information in this release contains “forward-looking” statements within the meaning of the U.S. Private Securities Litigation Reform
8-K
EX-99.1
MRMD
Marimed Inc.
20 Nov 23
Entry into a Material Definitive Agreement
5:03pm
statements which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. This press release contains
8-K
EX-10.2
MRMD
Marimed Inc.
20 Nov 23
Entry into a Material Definitive Agreement
5:03pm
in the business, properties or condition (financial or otherwise) of Guarantor since the date of the Guarantor Financials.
-5-
6100099.4
(g)Litigation
8-K
EX-10.1
MRMD
Marimed Inc.
20 Nov 23
Entry into a Material Definitive Agreement
5:03pm
, Federal and State Tax and Judgment/Litigation Liens searches for Borrower and Guarantor, all in such locations as Lender shall determine to be appropriate … ).
1.7.Litigation; Outstanding Orders. There are no actions, suits, proceedings or investigations pending or, to the Knowledge of Borrower threatened
8-K
EX-99.1
q3nz6uemjev8m2a0xr
8 Nov 23
MariMed Reports Third Quarter 2023 Earnings
5:06pm
8-K
EX-99.1
z2kd5tcorke8a
2 Aug 23
MariMed Reports Second Quarter 2023 Earnings
5:13pm
8-K
EX-99.1
07zo16
8 May 23
MariMed Reports First Quarter 2023 Earnings
5:03pm
8-K
EX-99.1
qjr 58oy1
17 Apr 23
MariMed Expands Board With the Addition of Kathleen Tucker
5:18pm
8-K
EX-99.1
d74cj
7 Nov 22
MariMed Reports Third Quarter 2022 Earnings
5:13pm
8-K
EX-99.1
plcigujf
5 Jan 22
MariMed Announces Agreement to Acquire Kind Therapeutics USA, LLC, A Maryland Licensed Vertically Integrated Cannabis Business
6:15am